297 related articles for article (PubMed ID: 25873774)
1. The role of the immune system in triplet repeat expansion diseases.
Olejniczak M; Urbanek MO; Krzyzosiak WJ
Mediators Inflamm; 2015; 2015():873860. PubMed ID: 25873774
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of RNA-induced toxicity in CAG repeat disorders.
Nalavade R; Griesche N; Ryan DP; Hildebrand S; Krauss S
Cell Death Dis; 2013 Aug; 4(8):e752. PubMed ID: 23907466
[TBL] [Abstract][Full Text] [Related]
3. Small non-coding RNAs add complexity to the RNA pathogenic mechanisms in trinucleotide repeat expansion diseases.
Martí E; Estivill X
Front Mol Neurosci; 2013 Dec; 6():45. PubMed ID: 24348326
[TBL] [Abstract][Full Text] [Related]
4. Triplet repeats in transcripts: structural insights into RNA toxicity.
Galka-Marciniak P; Urbanek MO; Krzyzosiak WJ
Biol Chem; 2012 Nov; 393(11):1299-315. PubMed ID: 23052488
[TBL] [Abstract][Full Text] [Related]
5. Polyglutamine expansion diseases: failing to deliver.
Morfini G; Pigino G; Brady ST
Trends Mol Med; 2005 Feb; 11(2):64-70. PubMed ID: 15694868
[TBL] [Abstract][Full Text] [Related]
6. [Aggregation and toxicity of the proteins with polyQ repeats].
Leźnicki P
Postepy Biochem; 2005; 51(2):215-22. PubMed ID: 16209359
[TBL] [Abstract][Full Text] [Related]
7. Proteins Containing Expanded Polyglutamine Tracts and Neurodegenerative Disease.
Adegbuyiro A; Sedighi F; Pilkington AW; Groover S; Legleiter J
Biochemistry; 2017 Mar; 56(9):1199-1217. PubMed ID: 28170216
[TBL] [Abstract][Full Text] [Related]
8. The pathogenic agent in Drosophila models of 'polyglutamine' diseases.
McLeod CJ; O'Keefe LV; Richards RI
Hum Mol Genet; 2005 Apr; 14(8):1041-8. PubMed ID: 15757976
[TBL] [Abstract][Full Text] [Related]
9. Assessing a peptidylic inhibitor-based therapeutic approach that simultaneously suppresses polyglutamine RNA- and protein-mediated toxicities in patient cells and Drosophila.
Zhang Q; Tsoi H; Peng S; Li PP; Lau KF; Rudnicki DD; Ngo JC; Chan HY
Dis Model Mech; 2016 Mar; 9(3):321-34. PubMed ID: 26839389
[TBL] [Abstract][Full Text] [Related]
10. Exploring the Potential of Small Molecule-Based Therapeutic Approaches for Targeting Trinucleotide Repeat Disorders.
Verma AK; Khan E; Bhagwat SR; Kumar A
Mol Neurobiol; 2020 Jan; 57(1):566-584. PubMed ID: 31399954
[TBL] [Abstract][Full Text] [Related]
11. Non-self mutation: double-stranded RNA elicits antiviral pathogenic response in a Drosophila model of expanded CAG repeat neurodegenerative diseases.
van Eyk CL; Samaraweera SE; Scott A; Webber DL; Harvey DP; Mecinger O; O'Keefe LV; Cropley JE; Young P; Ho J; Suter C; Richards RI
Hum Mol Genet; 2019 Sep; 28(18):3000-3012. PubMed ID: 31071221
[TBL] [Abstract][Full Text] [Related]
12. [Advances in understanding of clinical presentations and molecular mechanisms of triplet repeat diseases].
Tsuji S
Nihon Rinsho; 1999 Apr; 57(4):778-86. PubMed ID: 10222765
[TBL] [Abstract][Full Text] [Related]
13. Trinucleotide repeat expansion in neurological disease.
La Spada AR; Paulson HL; Fischbeck KH
Ann Neurol; 1994 Dec; 36(6):814-22. PubMed ID: 7998766
[TBL] [Abstract][Full Text] [Related]
14. Autophagy in polyglutamine disease: Imposing order on disorder or contributing to the chaos?
Cortes CJ; La Spada AR
Mol Cell Neurosci; 2015 May; 66(Pt A):53-61. PubMed ID: 25771431
[TBL] [Abstract][Full Text] [Related]
15. Modeling the polyglutamine aggregation pathway in Huntington's disease: from basic studies to clinical applications.
Sugaya K
Subcell Biochem; 2012; 65():353-88. PubMed ID: 23225011
[TBL] [Abstract][Full Text] [Related]
16. Allele-selective suppression of mutant genes in polyglutamine diseases.
Liu CR; Cheng TH
J Neurogenet; 2015; 29(2-3):41-9. PubMed ID: 26174158
[TBL] [Abstract][Full Text] [Related]
17. Comparative toxicity of polyglutamine, polyalanine and polyleucine tracts in Drosophila models of expanded repeat disease.
van Eyk CL; McLeod CJ; O'Keefe LV; Richards RI
Hum Mol Genet; 2012 Feb; 21(3):536-47. PubMed ID: 22021427
[TBL] [Abstract][Full Text] [Related]
18. [Research progress in roles of microRNA in polyglutamine diseases].
Shi YT; Jiang H; Tang BS
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2010 Aug; 27(4):406-9. PubMed ID: 20677146
[TBL] [Abstract][Full Text] [Related]
19. The pathogenic mechanisms of polyglutamine diseases and current therapeutic strategies.
Bauer PO; Nukina N
J Neurochem; 2009 Sep; 110(6):1737-65. PubMed ID: 19650870
[TBL] [Abstract][Full Text] [Related]
20. In Vitro Expansion of CAG, CAA, and Mixed CAG/CAA Repeats.
Figura G; Koscianska E; Krzyzosiak WJ
Int J Mol Sci; 2015 Aug; 16(8):18741-51. PubMed ID: 26270660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
